OraSure Technologies (OSUR) Competitors $2.98 -0.06 (-1.81%) As of 11:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. Its Competitors Cerus Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings. Do analysts prefer OSUR or CERS? OraSure Technologies presently has a consensus price target of $3.00, indicating a potential upside of 0.50%. Cerus has a consensus price target of $4.00, indicating a potential upside of 143.16%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Cerus 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is OSUR or CERS more profitable? Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies-36.84% -10.81% -9.44% Cerus -9.81%-33.77%-9.32% Which has better valuation & earnings, OSUR or CERS? OraSure Technologies has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.17-$19.50M-$0.67-4.46Cerus$192.51M1.64-$20.92M-$0.10-16.45 Which has more risk and volatility, OSUR or CERS? OraSure Technologies has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Does the media refer more to OSUR or CERS? In the previous week, Cerus had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Cerus and 1 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.75 beat Cerus' score of 0.50 indicating that OraSure Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in OSUR or CERS? 93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 3.9% of OraSure Technologies shares are owned by company insiders. Comparatively, 5.6% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryCerus beats OraSure Technologies on 11 of the 16 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$217.59M$10.66B$6.16B$10.63BDividend YieldN/A1.88%5.72%4.85%P/E Ratio-4.4420.7729.4627.34Price / Sales1.1732.57494.53190.41Price / Cash77.7925.1225.8230.35Price / Book0.543.4912.476.68Net Income-$19.50M$208.83M$3.32B$276.16M7 Day Performance-2.13%0.39%2.19%0.09%1 Month Performance-11.69%0.77%8.99%3.88%1 Year Performance-27.20%-7.86%64.06%33.52% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies2.2636 of 5 stars$2.99-1.8%$3.00+0.5%-26.7%$217.59M$185.83M-4.44840CERSCerus2.7313 of 5 stars$1.56-2.5%$3.50+124.4%-4.1%$306.72M$180.27M-15.60290News CoveragePositive NewsShort Interest ↓Gap DownUTMDUtah Medical Products2.08 of 5 stars$60.53-1.3%N/A-8.3%$196.61M$40.90M16.18180Upcoming EarningsANIKAnika Therapeutics4.5138 of 5 stars$9.10+0.9%$18.00+97.8%-61.5%$130.05M$119.91M-2.19300Positive NewsShort Interest ↓WSTWest Pharmaceutical Services4.7626 of 5 stars$262.77+0.4%$321.89+22.5%-6.3%$18.82B$2.89B39.3410,600Positive NewsUpcoming EarningsCOOCooper Companies3.4165 of 5 stars$69.30+1.4%$84.77+22.3%-30.7%$13.59B$3.90B34.1416,000Gap UpALGNAlign Technology4.8785 of 5 stars$129.54+3.0%$196.67+51.8%-38.6%$9.12B$4.00B21.8420,945Analyst ForecastMMSIMerit Medical Systems4.575 of 5 stars$79.43+0.6%$107.50+35.3%-13.8%$4.68B$1.36B40.327,400Positive NewsICUIICU Medical4.6758 of 5 stars$116.26+1.9%$181.00+55.7%-35.1%$2.82B$2.38B-76.4915,000Positive NewsAnalyst ForecastXRAYDENTSPLY SIRONA4.8479 of 5 stars$12.21+3.2%$18.00+47.4%-47.7%$2.36B$3.79B-2.5814,000Analyst DowngradeHAEHaemonetics4.9524 of 5 stars$50.25+2.9%$75.89+51.0%-33.4%$2.35B$1.36B15.373,023 Related Companies and Tools Related Companies Cerus Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Align Technology Competitors Merit Medical Systems Competitors ICU Medical Competitors DENTSPLY SIRONA Competitors Haemonetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OSUR Stock Alerts